The global market for Cell Therapy CDMO Services was valued at US$ 2135 million in the year 2024 and is projected to reach a revised size of US$ 7309 million by 2031, growing at a CAGR of 21.0% during the forecast period.

Cell Therapy CDMO Services Market

Cell therapy refers to the transfer of new cells, or cells that have been modified in a laboratory to achieve particular characteristics, into the body to prevent or treat a disease. A Contract Development and Manufacturing Organization (CDMO) is a company that provides comprehensive services to pharmaceutical, biotechnology, and medical device companies. CDMOs offer contract services for product development, formulation, manufacturing, packaging, and distribution. Contract development and manufacturing organizations (CDMOs) play a vital role in cell therapy development by offering crucial infrastructure and expertise.This report mainly focuses on cell therapy CDMO services market.

The cell therapy CDMO market is mainly concentrated in the following regions: North America (especially the United States) is the leader in the global cell therapy CDMO market, with advanced technology, a sound regulatory system and a large number of biopharmaceutical companies. The active support of the US FDA for cell therapy has also driven the growth of the market in the region. The European market also performed strongly, mainly due to the EU's support for cell therapy research and development and the regulatory framework of the EMA (European Medicines Agency). The United Kingdom, Germany and Switzerland are the main markets in Europe. The Asia-Pacific region (especially China, Japan and South Korea) is one of the fastest growing markets. The Chinese government's policy support and financial investment in the field of cell therapy, as well as Japan's leading position in regenerative medicine, have driven the rapid development of the market in the region. The markets in Latin America and the Middle East are relatively small, but with the popularization of cell therapy technology and the improvement of medical infrastructure, the market potential in these regions is gradually being released.

Challenges and Opportunities:

Challenges: The manufacturing process of cell therapy products is complex, requires high quality control, and is expensive. In addition, the instability of the global supply chain and the shortage of raw materials may also affect the delivery of CDMO services. Opportunities: With the advancement of technology and the optimization of manufacturing processes, CDMO companies have the opportunity to further expand their market share by providing efficient and low-cost services. In addition, the rise of emerging markets and the growing demand for personalized medicine have also provided new growth points for CDMO companies.

This report aims to provide a comprehensive presentation of the global market for Cell Therapy CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy CDMO Services.

The Cell Therapy CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell Therapy CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cell Therapy CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cell Therapy CDMO Services Market Report

Report Metric	Details
Report Name	Cell Therapy CDMO Services Market
Accounted market size in year	US$ 2135 million
Forecasted market size in 2031	US$ 7309 million
CAGR	21.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Preclinical Stage Clinical Commercialization Stage
Segment by Application	Pharmaceutical Company Research Institute
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Charles River Laboratories, AGC Biologics, FUJIFILM Cellular Dynamics, Thermo Fisher Scientific, Wuxi AppTec, Lonza, KBI Biopharma, RoslinCT, Cell and Gene Therapy Catapult, Cell Therapies, Minaris Regenerative Medicine, MEDINET, Catalent Biologics, Oxford BioMedica, GenScript, Cell-Easy, SK pharmteco
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Therapy CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cell Therapy CDMO Services Market growing?

Ans: The Cell Therapy CDMO Services Market witnessing a CAGR of 21.0% during the forecast period 2025-2031.

What is the Cell Therapy CDMO Services Market size in 2031?

Ans: The Cell Therapy CDMO Services Market size in 2031 will be US$ 7309 million.

Who are the main players in the Cell Therapy CDMO Services Market report?

Ans: The main players in the Cell Therapy CDMO Services Market are Charles River Laboratories, AGC Biologics, FUJIFILM Cellular Dynamics, Thermo Fisher Scientific, Wuxi AppTec, Lonza, KBI Biopharma, RoslinCT, Cell and Gene Therapy Catapult, Cell Therapies, Minaris Regenerative Medicine, MEDINET, Catalent Biologics, Oxford BioMedica, GenScript, Cell-Easy, SK pharmteco

What are the Application segmentation covered in the Cell Therapy CDMO Services Market report?

Ans: The Applications covered in the Cell Therapy CDMO Services Market report are Pharmaceutical Company, Research Institute

What are the Type segmentation covered in the Cell Therapy CDMO Services Market report?

Ans: The Types covered in the Cell Therapy CDMO Services Market report are Preclinical Stage, Clinical Commercialization Stage

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cell Therapy CDMO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Preclinical Stage

1.2.3 Clinical Commercialization Stage

1.3 Market by Application

1.3.1 Global Cell Therapy CDMO Services Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Company

1.3.3 Research Institute

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cell Therapy CDMO Services Market Perspective (2020-2031)

2.2 Global Cell Therapy CDMO Services Growth Trends by Region

2.2.1 Global Cell Therapy CDMO Services Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cell Therapy CDMO Services Historic Market Size by Region (2020-2025)

2.2.3 Cell Therapy CDMO Services Forecasted Market Size by Region (2026-2031)

2.3 Cell Therapy CDMO Services Market Dynamics

2.3.1 Cell Therapy CDMO Services Industry Trends

2.3.2 Cell Therapy CDMO Services Market Drivers

2.3.3 Cell Therapy CDMO Services Market Challenges

2.3.4 Cell Therapy CDMO Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cell Therapy CDMO Services Players by Revenue

3.1.1 Global Top Cell Therapy CDMO Services Players by Revenue (2020-2025)

3.1.2 Global Cell Therapy CDMO Services Revenue Market Share by Players (2020-2025)

3.2 Global Top Cell Therapy CDMO Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cell Therapy CDMO Services Revenue

3.4 Global Cell Therapy CDMO Services Market Concentration Ratio

3.4.1 Global Cell Therapy CDMO Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy CDMO Services Revenue in 2024

3.5 Global Key Players of Cell Therapy CDMO Services Head office and Area Served

3.6 Global Key Players of Cell Therapy CDMO Services, Product and Application

3.7 Global Key Players of Cell Therapy CDMO Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cell Therapy CDMO Services Breakdown Data by Type

4.1 Global Cell Therapy CDMO Services Historic Market Size by Type (2020-2025)

4.2 Global Cell Therapy CDMO Services Forecasted Market Size by Type (2026-2031)

5 Cell Therapy CDMO Services Breakdown Data by Application

5.1 Global Cell Therapy CDMO Services Historic Market Size by Application (2020-2025)

5.2 Global Cell Therapy CDMO Services Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Cell Therapy CDMO Services Market Size (2020-2031)

6.2 North America Cell Therapy CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cell Therapy CDMO Services Market Size by Country (2020-2025)

6.4 North America Cell Therapy CDMO Services Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cell Therapy CDMO Services Market Size (2020-2031)

7.2 Europe Cell Therapy CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cell Therapy CDMO Services Market Size by Country (2020-2025)

7.4 Europe Cell Therapy CDMO Services Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cell Therapy CDMO Services Market Size (2020-2031)

8.2 Asia-Pacific Cell Therapy CDMO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cell Therapy CDMO Services Market Size by Region (2020-2025)

8.4 Asia-Pacific Cell Therapy CDMO Services Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cell Therapy CDMO Services Market Size (2020-2031)

9.2 Latin America Cell Therapy CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cell Therapy CDMO Services Market Size by Country (2020-2025)

9.4 Latin America Cell Therapy CDMO Services Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cell Therapy CDMO Services Market Size (2020-2031)

10.2 Middle East & Africa Cell Therapy CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cell Therapy CDMO Services Market Size by Country (2020-2025)

10.4 Middle East & Africa Cell Therapy CDMO Services Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Charles River Laboratories

11.1.1 Charles River Laboratories Company Details

11.1.2 Charles River Laboratories Business Overview

11.1.3 Charles River Laboratories Cell Therapy CDMO Services Introduction

11.1.4 Charles River Laboratories Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.1.5 Charles River Laboratories Recent Development

11.2 AGC Biologics

11.2.1 AGC Biologics Company Details

11.2.2 AGC Biologics Business Overview

11.2.3 AGC Biologics Cell Therapy CDMO Services Introduction

11.2.4 AGC Biologics Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.2.5 AGC Biologics Recent Development

11.3 FUJIFILM Cellular Dynamics

11.3.1 FUJIFILM Cellular Dynamics Company Details

11.3.2 FUJIFILM Cellular Dynamics Business Overview

11.3.3 FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Introduction

11.3.4 FUJIFILM Cellular Dynamics Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.3.5 FUJIFILM Cellular Dynamics Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Details

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Cell Therapy CDMO Services Introduction

11.4.4 Thermo Fisher Scientific Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 Wuxi AppTec

11.5.1 Wuxi AppTec Company Details

11.5.2 Wuxi AppTec Business Overview

11.5.3 Wuxi AppTec Cell Therapy CDMO Services Introduction

11.5.4 Wuxi AppTec Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.5.5 Wuxi AppTec Recent Development

11.6 Lonza

11.6.1 Lonza Company Details

11.6.2 Lonza Business Overview

11.6.3 Lonza Cell Therapy CDMO Services Introduction

11.6.4 Lonza Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.6.5 Lonza Recent Development

11.7 KBI Biopharma

11.7.1 KBI Biopharma Company Details

11.7.2 KBI Biopharma Business Overview

11.7.3 KBI Biopharma Cell Therapy CDMO Services Introduction

11.7.4 KBI Biopharma Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.7.5 KBI Biopharma Recent Development

11.8 RoslinCT

11.8.1 RoslinCT Company Details

11.8.2 RoslinCT Business Overview

11.8.3 RoslinCT Cell Therapy CDMO Services Introduction

11.8.4 RoslinCT Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.8.5 RoslinCT Recent Development

11.9 Cell and Gene Therapy Catapult

11.9.1 Cell and Gene Therapy Catapult Company Details

11.9.2 Cell and Gene Therapy Catapult Business Overview

11.9.3 Cell and Gene Therapy Catapult Cell Therapy CDMO Services Introduction

11.9.4 Cell and Gene Therapy Catapult Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.9.5 Cell and Gene Therapy Catapult Recent Development

11.10 Cell Therapies

11.10.1 Cell Therapies Company Details

11.10.2 Cell Therapies Business Overview

11.10.3 Cell Therapies Cell Therapy CDMO Services Introduction

11.10.4 Cell Therapies Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.10.5 Cell Therapies Recent Development

11.11 Minaris Regenerative Medicine

11.11.1 Minaris Regenerative Medicine Company Details

11.11.2 Minaris Regenerative Medicine Business Overview

11.11.3 Minaris Regenerative Medicine Cell Therapy CDMO Services Introduction

11.11.4 Minaris Regenerative Medicine Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.11.5 Minaris Regenerative Medicine Recent Development

11.12 MEDINET

11.12.1 MEDINET Company Details

11.12.2 MEDINET Business Overview

11.12.3 MEDINET Cell Therapy CDMO Services Introduction

11.12.4 MEDINET Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.12.5 MEDINET Recent Development

11.13 Catalent Biologics

11.13.1 Catalent Biologics Company Details

11.13.2 Catalent Biologics Business Overview

11.13.3 Catalent Biologics Cell Therapy CDMO Services Introduction

11.13.4 Catalent Biologics Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.13.5 Catalent Biologics Recent Development

11.14 Oxford BioMedica

11.14.1 Oxford BioMedica Company Details

11.14.2 Oxford BioMedica Business Overview

11.14.3 Oxford BioMedica Cell Therapy CDMO Services Introduction

11.14.4 Oxford BioMedica Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.14.5 Oxford BioMedica Recent Development

11.15 GenScript

11.15.1 GenScript Company Details

11.15.2 GenScript Business Overview

11.15.3 GenScript Cell Therapy CDMO Services Introduction

11.15.4 GenScript Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.15.5 GenScript Recent Development

11.16 Cell-Easy

11.16.1 Cell-Easy Company Details

11.16.2 Cell-Easy Business Overview

11.16.3 Cell-Easy Cell Therapy CDMO Services Introduction

11.16.4 Cell-Easy Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.16.5 Cell-Easy Recent Development

11.17 SK pharmteco

11.17.1 SK pharmteco Company Details

11.17.2 SK pharmteco Business Overview

11.17.3 SK pharmteco Cell Therapy CDMO Services Introduction

11.17.4 SK pharmteco Revenue in Cell Therapy CDMO Services Business (2020-2025)

11.17.5 SK pharmteco Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Lonza

GenScript

Oxford BioMedica

Charles River Laboratories

AGC Biologics

Fujifilm Cellular Dynamics

Thermo Fisher Scientific

WuXi AppTec

KBI Biopharma

RoslinCT

Cell and Gene Therapy Catapult

Cell Therapies

Minaris Regenerative Medicine

List of Tables

Table 1. Global Cell Therapy CDMO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Preclinical Stage

Table 3. Key Players of Clinical Commercialization Stage

Table 4. Global Cell Therapy CDMO Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Cell Therapy CDMO Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Cell Therapy CDMO Services Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Cell Therapy CDMO Services Market Share by Region (2020-2025)

Table 8. Global Cell Therapy CDMO Services Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Cell Therapy CDMO Services Market Share by Region (2026-2031)

Table 10. Cell Therapy CDMO Services Market Trends

Table 11. Cell Therapy CDMO Services Market Drivers

Table 12. Cell Therapy CDMO Services Market Challenges

Table 13. Cell Therapy CDMO Services Market Restraints

Table 14. Global Cell Therapy CDMO Services Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Cell Therapy CDMO Services Market Share by Players (2020-2025)

Table 16. Global Top Cell Therapy CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CDMO Services as of 2024)

Table 17. Ranking of Global Top Cell Therapy CDMO Services Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Cell Therapy CDMO Services Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Cell Therapy CDMO Services, Headquarters and Area Served

Table 20. Global Key Players of Cell Therapy CDMO Services, Product and Application

Table 21. Global Key Players of Cell Therapy CDMO Services, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Cell Therapy CDMO Services Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Cell Therapy CDMO Services Revenue Market Share by Type (2020-2025)

Table 25. Global Cell Therapy CDMO Services Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Cell Therapy CDMO Services Revenue Market Share by Type (2026-2031)

Table 27. Global Cell Therapy CDMO Services Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Cell Therapy CDMO Services Revenue Market Share by Application (2020-2025)

Table 29. Global Cell Therapy CDMO Services Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Cell Therapy CDMO Services Revenue Market Share by Application (2026-2031)

Table 31. North America Cell Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Cell Therapy CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Cell Therapy CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Cell Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Cell Therapy CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Cell Therapy CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Cell Therapy CDMO Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Cell Therapy CDMO Services Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Cell Therapy CDMO Services Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Cell Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Cell Therapy CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Cell Therapy CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Cell Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Cell Therapy CDMO Services Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Cell Therapy CDMO Services Market Size by Country (2026-2031) & (US$ Million)

Table 46. Charles River Laboratories Company Details

Table 47. Charles River Laboratories Business Overview

Table 48. Charles River Laboratories Cell Therapy CDMO Services Product

Table 49. Charles River Laboratories Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 50. Charles River Laboratories Recent Development

Table 51. AGC Biologics Company Details

Table 52. AGC Biologics Business Overview

Table 53. AGC Biologics Cell Therapy CDMO Services Product

Table 54. AGC Biologics Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 55. AGC Biologics Recent Development

Table 56. FUJIFILM Cellular Dynamics Company Details

Table 57. FUJIFILM Cellular Dynamics Business Overview

Table 58. FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Product

Table 59. FUJIFILM Cellular Dynamics Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 60. FUJIFILM Cellular Dynamics Recent Development

Table 61. Thermo Fisher Scientific Company Details

Table 62. Thermo Fisher Scientific Business Overview

Table 63. Thermo Fisher Scientific Cell Therapy CDMO Services Product

Table 64. Thermo Fisher Scientific Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 65. Thermo Fisher Scientific Recent Development

Table 66. Wuxi AppTec Company Details

Table 67. Wuxi AppTec Business Overview

Table 68. Wuxi AppTec Cell Therapy CDMO Services Product

Table 69. Wuxi AppTec Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 70. Wuxi AppTec Recent Development

Table 71. Lonza Company Details

Table 72. Lonza Business Overview

Table 73. Lonza Cell Therapy CDMO Services Product

Table 74. Lonza Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 75. Lonza Recent Development

Table 76. KBI Biopharma Company Details

Table 77. KBI Biopharma Business Overview

Table 78. KBI Biopharma Cell Therapy CDMO Services Product

Table 79. KBI Biopharma Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 80. KBI Biopharma Recent Development

Table 81. RoslinCT Company Details

Table 82. RoslinCT Business Overview

Table 83. RoslinCT Cell Therapy CDMO Services Product

Table 84. RoslinCT Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 85. RoslinCT Recent Development

Table 86. Cell and Gene Therapy Catapult Company Details

Table 87. Cell and Gene Therapy Catapult Business Overview

Table 88. Cell and Gene Therapy Catapult Cell Therapy CDMO Services Product

Table 89. Cell and Gene Therapy Catapult Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 90. Cell and Gene Therapy Catapult Recent Development

Table 91. Cell Therapies Company Details

Table 92. Cell Therapies Business Overview

Table 93. Cell Therapies Cell Therapy CDMO Services Product

Table 94. Cell Therapies Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 95. Cell Therapies Recent Development

Table 96. Minaris Regenerative Medicine Company Details

Table 97. Minaris Regenerative Medicine Business Overview

Table 98. Minaris Regenerative Medicine Cell Therapy CDMO Services Product

Table 99. Minaris Regenerative Medicine Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 100. Minaris Regenerative Medicine Recent Development

Table 101. MEDINET Company Details

Table 102. MEDINET Business Overview

Table 103. MEDINET Cell Therapy CDMO Services Product

Table 104. MEDINET Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 105. MEDINET Recent Development

Table 106. Catalent Biologics Company Details

Table 107. Catalent Biologics Business Overview

Table 108. Catalent Biologics Cell Therapy CDMO Services Product

Table 109. Catalent Biologics Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 110. Catalent Biologics Recent Development

Table 111. Oxford BioMedica Company Details

Table 112. Oxford BioMedica Business Overview

Table 113. Oxford BioMedica Cell Therapy CDMO Services Product

Table 114. Oxford BioMedica Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 115. Oxford BioMedica Recent Development

Table 116. GenScript Company Details

Table 117. GenScript Business Overview

Table 118. GenScript Cell Therapy CDMO Services Product

Table 119. GenScript Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 120. GenScript Recent Development

Table 121. Cell-Easy Company Details

Table 122. Cell-Easy Business Overview

Table 123. Cell-Easy Cell Therapy CDMO Services Product

Table 124. Cell-Easy Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 125. Cell-Easy Recent Development

Table 126. SK pharmteco Company Details

Table 127. SK pharmteco Business Overview

Table 128. SK pharmteco Cell Therapy CDMO Services Product

Table 129. SK pharmteco Revenue in Cell Therapy CDMO Services Business (2020-2025) & (US$ Million)

Table 130. SK pharmteco Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

Table 134. Authors List of This Report

List of Figures

Figure 1. Cell Therapy CDMO Services Picture

Figure 2. Global Cell Therapy CDMO Services Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cell Therapy CDMO Services Market Share by Type: 2024 VS 2031

Figure 4. Preclinical Stage Features

Figure 5. Clinical Commercialization Stage Features

Figure 6. Global Cell Therapy CDMO Services Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Cell Therapy CDMO Services Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceutical Company Case Studies

Figure 9. Research Institute Case Studies

Figure 10. Cell Therapy CDMO Services Report Years Considered

Figure 11. Global Cell Therapy CDMO Services Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Cell Therapy CDMO Services Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Cell Therapy CDMO Services Market Share by Region: 2024 VS 2031

Figure 14. Global Cell Therapy CDMO Services Market Share by Players in 2024

Figure 15. Global Cell Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 16. The Top 10 and 5 Players Market Share by Cell Therapy CDMO Services Revenue in 2024

Figure 17. North America Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Cell Therapy CDMO Services Market Share by Country (2020-2031)

Figure 19. United States Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Cell Therapy CDMO Services Market Share by Country (2020-2031)

Figure 23. Germany Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Cell Therapy CDMO Services Market Share by Region (2020-2031)

Figure 31. China Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Cell Therapy CDMO Services Market Share by Country (2020-2031)

Figure 39. Mexico Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Cell Therapy CDMO Services Market Share by Country (2020-2031)

Figure 43. Turkey Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Cell Therapy CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Charles River Laboratories Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 47. AGC Biologics Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 48. FUJIFILM Cellular Dynamics Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 50. Wuxi AppTec Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 51. Lonza Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 52. KBI Biopharma Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 53. RoslinCT Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 54. Cell and Gene Therapy Catapult Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 55. Cell Therapies Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 56. Minaris Regenerative Medicine Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 57. MEDINET Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 58. Catalent Biologics Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 59. Oxford BioMedica Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 60. GenScript Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 61. Cell-Easy Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 62. SK pharmteco Revenue Growth Rate in Cell Therapy CDMO Services Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pediatric Splint Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23P18775

Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Liquid Calcium Zinc Stabilizer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32K10461

Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Electromagnetic Navigation Bronchoscopy (ENB) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-31H11079

Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global In Vivo Imaging Systems Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18N2021

Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions